1. Home
  2. ASIX vs KALV Comparison

ASIX vs KALV Comparison

Compare ASIX & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ASIX

AdvanSix Inc.

HOLD

Current Price

$17.77

Market Cap

466.9M

Sector

Industrials

ML Signal

HOLD

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$15.79

Market Cap

551.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASIX
KALV
Founded
2016
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
466.9M
551.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ASIX
KALV
Price
$17.77
$15.79
Analyst Decision
Buy
Strong Buy
Analyst Count
1
6
Target Price
$32.00
$27.83
AVG Volume (30 Days)
736.2K
992.0K
Earning Date
02-20-2026
11-10-2025
Dividend Yield
3.84%
N/A
EPS Growth
35.47
N/A
EPS
1.92
N/A
Revenue
$1,491,348,000.00
$1,426,000.00
Revenue This Year
$4.71
N/A
Revenue Next Year
$4.59
$204.16
P/E Ratio
$8.68
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.10
$7.30
52 Week High
$32.58
$17.30

Technical Indicators

Market Signals
Indicator
ASIX
KALV
Relative Strength Index (RSI) 61.23 55.48
Support Level $17.10 $15.12
Resistance Level $17.69 $16.45
Average True Range (ATR) 0.59 0.90
MACD 0.11 -0.13
Stochastic Oscillator 100.00 46.65

Price Performance

Historical Comparison
ASIX
KALV

About ASIX AdvanSix Inc.

AdvanSix Inc. is a diversified chemistry company playing a critical role in globally supply chains, innovating and delivering essential products for customers in a wide variety of end markets and applications that touch people's lives, such as building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives and electronics. The company key products includes: Nylon, Caprolactam, Plant Nutrients, and Chemical Intermediates The majority of sales is from Plant Nutrients products.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

Share on Social Networks: